MERANDA MAYER: Open Payments
NPI 1467143636 · NEW BRUNSWICK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,378 in 73 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $669 · 2025 $1,378
Food & beverage: $1,378
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 17 | $323 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $188 |
| ABBVIE INC. | 14 | $168 |
| Novartis Pharmaceuticals Corporation | 3 | $102 |
| Regeneron Healthcare Solutions, Inc. | 5 | $82 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 4 | $74 |
| Incyte Corporation | 4 | $73 |
| UCB, Inc. | 4 | $70 |
| Journey Medical Corporation | 2 | $42 |
| Lilly USA, LLC | 2 | $41 |
Products named: NEMLUVIO, AKLIEF, ILUMYA, SKYRIZI, Cabtreo, OPZELURA, Bimzelx, Winlevi.
Industry payments across NJ — which companies pay providers there.
